Growth at Reasonable Price
Results
6
2 new
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DOV | €2.30 | -3.0% | 1.3% | €436.2m | €3.30 | 0.8 | 68.3% | 4.0% | Commercial Services | ||
FCT New | €11.58 | 6.2% | -29.7% | €4.1b | €17.23 | 33.6 | 28.8% | 0% | Capital Goods | ||
FF | €8.94 | -1.5% | 12.6% | €210.3m | €13.06 | 30.5 | 32.3% | 1.8% | Pharmaceuticals & Biotech | ||
MFEB | €3.52 | -0.8% | -7.6% | €2.1b | €4.24 | 11.0 | 20.5% | 6.2% | Media | ||
ZV New | €7.18 | -3.4% | -16.8% | €633.7m | €8.70 | 19.5 | 20.4% | 3.1% | Materials | ||
REC | €51.30 | -0.1% | -5.8% | €10.4b | €59.06 | 22.1 | 15.3% | 2.6% | Pharmaceuticals & Biotech |
Page 1 of 1